{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T18:04:29Z","timestamp":1779559469856,"version":"3.53.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,23]]},"DOI":"10.7759\/cureus.109513","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:13:53Z","timestamp":1779556433000},"source":"Crossref","is-referenced-by-count":0,"title":["Co-occurrence of Kikuchi-Fujimoto Disease, Systemic Lupus Erythematosus, and Macrophage Activation Syndrome Presenting With Acute Pancreatitis and Myositis in an Adolescent Male Patient"],"prefix":"10.7759","author":[{"given":"Amit R","family":"Rup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinnera","family":"Sailaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema Latha","family":"Gundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keertthana","family":"Padmanaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnalata","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akruti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal K","family":"Mohakud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Lymphadenitis showing reticulum cell hyperplasia with nuclear debris and phagocytes","volume":"53","author":"Kikuchi M","year":"1972","unstructured":"Kikuchi M. Lymphadenitis showing reticulum cell hyperplasia with nuclear debris and phagocytes. Acta Hematol Jpn. 1972, 53:379-380.","journal-title":"Acta Hematol Jpn"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1309\/YF081L4TKYWVYVPQ","article-title":"Enigmatic Kikuchi-Fujimoto disease: a comprehensive review","volume":"122","author":"Bosch X","year":"2004","unstructured":"Bosch X, Guilabert A, Miquel R, Campo E. Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol. 2004, 122:141-152.","journal-title":"Am J Clin Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019, 71:1400-1412. 10.1136\/annrheumdis-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S106396","article-title":"Kikuchi-Fujimoto disease and systemic lupus erythematosus","volume":"9","author":"Baenas DF","year":"2016","unstructured":"Baenas DF, Diehl FA, Haye Salinas MJ, Riva V, Diller A, Lemos PA. Kikuchi-Fujimoto disease and systemic lupus erythematosus. Int Med Case Rep J. 2016, 9:163-7. 10.2147\/IMCRJ.S106396","journal-title":"Int Med Case Rep J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"75","author":"Ravelli A","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al.. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis. 2016, 75:481-9. 10.1136\/annrheumdis-2015-208982","journal-title":"Ann Rheum Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand PE","year":"2017","unstructured":"Gavand PE, Serio I, Arnaud L, et al.. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev. 2017, 16:743-9. 10.1016\/j.autrev.2017.05.010","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-022-03703-6","article-title":"Kikuchi-Fujimoto disease as the initial manifestation of systemic lupus erythematosus complicated with macrophage activation syndrome: two case reports and a review of literature","volume":"22","author":"Liu C","year":"2022","unstructured":"Liu C, Jin Y, Huang H, et al.. Kikuchi-Fujimoto disease as the initial manifestation of systemic lupus erythematosus complicated with macrophage activation syndrome: two case reports and a review of literature. BMC Pediatr. 2022, 22:673. 10.1186\/s12887-022-03703-6","journal-title":"BMC Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom AA","year":"2016","unstructured":"Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016, 12:259-68. 10.1038\/nrrheum.2015.179","journal-title":"Nat Rev Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne CB","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019, 10:119. 10.3389\/fimmu.2019.00119","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15900","article-title":"Hyperinflammation: on the pathogenesis and treatment of macrophage activation syndrome","volume":"110","author":"Andersson U","year":"2021","unstructured":"Andersson U. Hyperinflammation: on the pathogenesis and treatment of macrophage activation syndrome. Acta Paediatr. 2021, 110:2717-22. 10.1111\/apa.15900","journal-title":"Acta Paediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter SJ","year":"2019","unstructured":"Carter SJ, Tattersall RS, Ramanan AV. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology (Oxford). 2019, 58:5-17. 10.1093\/rheumatology\/key006","journal-title":"Rheumatology (Oxford)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.02.048","article-title":"Multifocal infantile hemangioma","volume":"210","author":"Uda K","year":"2019","unstructured":"Uda K, Okubo Y, Matsushima T, Sadahira C, Kono T, Hataya H. Multifocal infantile hemangioma. J Pediatr. 2019, 210:238-238.e1. 10.1016\/j.jpeds.2019.02.048","journal-title":"J Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri M","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, et al.. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2677-86. 10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.38769","article-title":"Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"66","author":"Dav\u00ec S","year":"2014","unstructured":"Dav\u00ec S, Minoia F, Pistorio A, et al.. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2014, 66:2871-80. 10.1002\/art.38769","journal-title":"Arthritis Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/art.40417","article-title":"Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus","volume":"70","author":"Borgia RE","year":"2018","unstructured":"Borgia RE, Gerstein M, Levy DM, Silverman ED, Hiraki LT. Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2018, 70:616-24. 10.1002\/art.40417","journal-title":"Arthritis Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i16.3664","article-title":"Kikuchi-Fujimoto disease: a comprehensive review","volume":"11","author":"Rani R","year":"2023","unstructured":"Rani R, Sharma N, Sharma V, Mahajan VK. Kikuchi-Fujimoto disease: a comprehensive review. World J Clin Cases. 2023, 11:3664-79. 10.12998\/wjcc.v11.i16.3664","journal-title":"World J Clin Cases"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.906475","article-title":"Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus","volume":"9","author":"Kim JW","year":"2022","unstructured":"Kim JW, Kim HA, Suh CH, Jung JY. Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus. Front Med (Lausanne). 2022, 9:906475. 10.3389\/fmed.2022.906475","journal-title":"Front Med (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.11.001","article-title":"Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus","volume":"38","author":"Strickland FM","year":"2012","unstructured":"Strickland FM, Hewagama A, Lu Q, et al.. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J Autoimmun. 2012, 38:J135-43. 10.1016\/j.jaut.2011.11.001","journal-title":"J Autoimmun"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.32677\/IJCH.2019.v06.i05.015","article-title":"Kikuchi-Fujimoto disease in an adolescent girl with discoid skin lesion and high serum ferritin - a rare case report from Odisha","volume":"6","author":"Biswal S","year":"2019","unstructured":"Biswal S, Dash AK, Kumar M, Mohakud NK. Kikuchi-Fujimoto disease in an adolescent girl with discoid skin lesion and high serum ferritin - a rare case report from Odisha.  Indian J Child Health. 2019, 6:251-254.","journal-title":"Indian J Child Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1961585","article-title":"Efficacy of cyclosporine in the induction and maintenance of remission in a systemic lupus erythematosus patient presenting with macrophage-activating syndrome","volume":"2018","author":"Cruz-P\u00e9rez F","year":"2018","unstructured":"Cruz-P\u00e9rez F, Vil\u00e1 S, R\u00edos G, Vil\u00e1 LM. Efficacy of cyclosporine in the induction and maintenance of remission in a systemic lupus erythematosus patient presenting with macrophage-activating syndrome. Case Rep Rheumatol. 2018, 2018:1961585. 10.1155\/2018\/1961585","journal-title":"Case Rep Rheumatol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris L","year":"2005","unstructured":"Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al.. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005, 64:620-625.","journal-title":"Ann Rheum Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1784529","article-title":"Evaluation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis: a single center experience","volume":"2022","author":"H\u00f8eg PE","year":"2022","unstructured":"H\u00f8eg PE, Glerup M, Mahler B, H\u00f8st C, Herlin T. Evaluation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis: a single center experience. Int J Rheumatol. 2022, 2022:1784529. 10.1155\/2022\/1784529","journal-title":"Int J Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand EF","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y, et al.. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020, 382:211-21. 10.1056\/NEJMoa1912196","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495206-co-occurrence-of-kikuchi-fujimoto-disease-systemic-lupus-erythematosus-and-macrophage-activation-syndrome-presenting-with-acute-pancreatitis-and-myositis-in-an-adolescent-male-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:13:54Z","timestamp":1779556434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495206-co-occurrence-of-kikuchi-fujimoto-disease-systemic-lupus-erythematosus-and-macrophage-activation-syndrome-presenting-with-acute-pancreatitis-and-myositis-in-an-adolescent-male-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.109513","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,23]]}}}